CRISPR and CRISPR-associated (Cas) Genes Market Report

China CRISPR and CRISPR-associated (Cas) Genes Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：191
  • REPORT CODE：GMM1805944
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the CRISPR and CRISPR-associated (Cas) Genes industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • GE Healthcare Dharmacon

    • Mirus Bio LLC

    • Caribou Biosciences

    • Thermo Fisher Scientific

    • Addgene

    • CRISPR THERAPEUTICS

    • Merck KGaA

    • Editas Medicine

    • Horizon Discovery Group

    By Type:

    • CRISPR Plasmid

    • Genome Editing

    • gRNA Database/Gene Librar

    • Genetically Modified Organisms/Crops

    • Cell Line Engineering

    • Human Stem Cells

    • Genetic Engineering

    By Application:

    • Academic Institutes

    • Pharmaceutical Companies

    • Research and Development Institutes

    • Biotechnology Companies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China CRISPR and CRISPR-associated (Cas) Genes Market Overview 2018-2029

    • 1.1 China CRISPR and CRISPR-associated (Cas) Genes Industry Development Overview

    • 1.2 China CRISPR and CRISPR-associated (Cas) Genes Industry Development History

    • 1.3 China CRISPR and CRISPR-associated (Cas) Genes Industry Market Size (2018-2029)

    • 1.4 China CRISPR and CRISPR-associated (Cas) Genes Market Analysis by Type from Production Side

      • 1.4.1 China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of CRISPR Plasmid (2018-2029)

      • 1.4.2 China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Genome Editing (2018-2029)

      • 1.4.3 China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of gRNA Database/Gene Librar (2018-2029)

      • 1.4.4 China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Genetically Modified Organisms/Crops (2018-2029)

      • 1.4.5 China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Cell Line Engineering (2018-2029)

      • 1.4.6 China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Human Stem Cells (2018-2029)

      • 1.4.7 China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Genetic Engineering (2018-2029)

    • 1.5 China CRISPR and CRISPR-associated (Cas) Genes Market Analysis by Application from Consumption End

      • 1.5.1 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate of Academic Institutes (2018-2029)

      • 1.5.2 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate of Pharmaceutical Companies (2018-2029)

      • 1.5.3 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate of Research and Development Institutes (2018-2029)

      • 1.5.4 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate of Biotechnology Companies (2018-2029)

    • 1.6 China CRISPR and CRISPR-associated (Cas) Genes Market Analysis by Region

      • 1.6.1 North China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

    Chapter 2 China CRISPR and CRISPR-associated (Cas) Genes Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on CRISPR and CRISPR-associated (Cas) Genes Market Status and Competition at home and abroad in 2023

      • 2.2.2 China CRISPR and CRISPR-associated (Cas) Genes Market Status and Competition Analysis in 2023

      • 2.2.3 China CRISPR and CRISPR-associated (Cas) Genes Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China CRISPR and CRISPR-associated (Cas) Genes Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on CRISPR and CRISPR-associated (Cas) Genes Industry Development

    Chapter 3 CRISPR and CRISPR-associated (Cas) GenesIndustry Chain Analysis

    • 3.1 CRISPR and CRISPR-associated (Cas) Genes Industry Chain

    • 3.2 CRISPR and CRISPR-associated (Cas) Genes Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the CRISPR and CRISPR-associated (Cas) Genes Market

    • 3.3 CRISPR and CRISPR-associated (Cas) Genes Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the CRISPR and CRISPR-associated (Cas) Genes Market

    Chapter 4 China CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 4.1 China CRISPR and CRISPR-associated (Cas) Genes Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China CRISPR and CRISPR-associated (Cas) Genes Total Production Volume and Growth Rate from Production Side

    • 4.5 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate, by Type

      • 4.5.1 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of CRISPR Plasmid

      • 4.5.2 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Genome Editing

      • 4.5.3 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of gRNA Database/Gene Librar

      • 4.5.4 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Genetically Modified Organisms/Crops

      • 4.5.5 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Cell Line Engineering

      • 4.5.6 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Human Stem Cells

      • 4.5.7 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Genetic Engineering

    Chapter 5 China CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China CRISPR and CRISPR-associated (Cas) Genes Total Market Size and Growth Rate from Consumption End

    • 5.5 China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate, by Application

      • 5.5.1 China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Academic Institutes

      • 5.5.2 China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Pharmaceutical Companies

      • 5.5.3 China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Research and Development Institutes

      • 5.5.4 China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Biotechnology Companies

    Chapter 6 China CRISPR and CRISPR-associated (Cas) Genes Market, by Region

    • 6.1 China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Production Value, by Region

    • 6.2 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Sales Value, by Region

    Chapter 7 North China CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 7.1 North China CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 7.2 North China CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    Chapter 8 Central China CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 8.1 Central China CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 8.2 Central China CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    Chapter 9 South China CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 9.1 South China CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 9.2 South China CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    Chapter 10 East China CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 10.1 East China CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 10.2 East China CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    Chapter 11 Northeast China CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 11.1 Northeast China CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 11.2 Northeast China CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    Chapter 12 Southwest China CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 12.1 Southwest China CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 12.2 Southwest China CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    Chapter 13 Northwest China CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 13.1 Northwest China CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 13.2 Northwest China CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    Chapter 14 Company Profiles

      • 14.1 GE Healthcare Dharmacon

        • 14.1.1 GE Healthcare Dharmacon Company Profile

        • 14.1.2 GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Mirus Bio LLC

        • 14.2.1 Mirus Bio LLC Company Profile

        • 14.2.2 Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Caribou Biosciences

        • 14.3.1 Caribou Biosciences Company Profile

        • 14.3.2 Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Thermo Fisher Scientific

        • 14.4.1 Thermo Fisher Scientific Company Profile

        • 14.4.2 Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Addgene

        • 14.5.1 Addgene Company Profile

        • 14.5.2 Addgene CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 CRISPR THERAPEUTICS

        • 14.6.1 CRISPR THERAPEUTICS Company Profile

        • 14.6.2 CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck KGaA

        • 14.7.1 Merck KGaA Company Profile

        • 14.7.2 Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Editas Medicine

        • 14.8.1 Editas Medicine Company Profile

        • 14.8.2 Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Horizon Discovery Group

        • 14.9.1 Horizon Discovery Group Company Profile

        • 14.9.2 Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 CRISPR and CRISPR-associated (Cas) Genes Industry Research Conclusions

    • 15.2 CRISPR and CRISPR-associated (Cas) Genes Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Industry Market Size (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of CRISPR Plasmid (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Genome Editing (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of gRNA Database/Gene Librar (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Genetically Modified Organisms/Crops (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Cell Line Engineering (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Human Stem Cells (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume, Production Value and Growth Rate of Genetic Engineering (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate of Academic Institutes (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate of Pharmaceutical Companies (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate of Research and Development Institutes (2018-2029)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate of Biotechnology Companies (2018-2029)

    • Figure North China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

    • Figure Central China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

    • Figure South China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

    • Figure East China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

    • Figure Northeast China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

    • Figure Southwest China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

    • Figure Northwest China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate from 2018-2029

    • Figure CRISPR and CRISPR-associated (Cas) Genes Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Market Share by Type in 2018

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Market Share by Type in 2023

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of CRISPR Plasmid (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Genome Editing (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of gRNA Database/Gene Librar (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Genetically Modified Organisms/Crops (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Cell Line Engineering (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Human Stem Cells (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume and Growth Rate of Genetic Engineering (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Market Share by Application in 2018

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Market Share by Application in 2023

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Total Market Size and Growth Rate from Consumption End

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Academic Institutes (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Pharmaceutical Companies (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Research and Development Institutes (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Biotechnology Companies (2018-2023)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Production Volume by Region (2018-2023)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Region (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Region (2018-2023)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Production Value by Region (2018-2023)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Production Value Share by Region (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Value Share by Region (2018-2023)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Volume by Region (2018-2023)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Region (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Region (2018-2023)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Value by Region (2018-2023)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Value Share by Region (2018-2023)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Value Share by Region (2018-2023)

    • Table North China CRISPR and CRISPR-associated (Cas) Genes Production Volume by Type (2018-2023)

    • Table North China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Figure North China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Table North China CRISPR and CRISPR-associated (Cas) Genes Sales Volume by Application (2018-2023)

    • Table North China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Figure North China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Table Central China CRISPR and CRISPR-associated (Cas) Genes Production Volume by Type (2018-2023)

    • Table Central China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Figure Central China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Table Central China CRISPR and CRISPR-associated (Cas) Genes Sales Volume by Application (2018-2023)

    • Table Central China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Figure Central China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Table South China CRISPR and CRISPR-associated (Cas) Genes Production Volume by Type (2018-2023)

    • Table South China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Figure South China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Table South China CRISPR and CRISPR-associated (Cas) Genes Sales Volume by Application (2018-2023)

    • Table South China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Figure South China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Table East China CRISPR and CRISPR-associated (Cas) Genes Production Volume by Type (2018-2023)

    • Table East China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Figure East China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Table East China CRISPR and CRISPR-associated (Cas) Genes Sales Volume by Application (2018-2023)

    • Table East China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Figure East China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Table Northeast China CRISPR and CRISPR-associated (Cas) Genes Production Volume by Type (2018-2023)

    • Table Northeast China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Figure Northeast China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Table Northeast China CRISPR and CRISPR-associated (Cas) Genes Sales Volume by Application (2018-2023)

    • Table Northeast China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Figure Northeast China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Table Southwest China CRISPR and CRISPR-associated (Cas) Genes Production Volume by Type (2018-2023)

    • Table Southwest China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Figure Southwest China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Table Southwest China CRISPR and CRISPR-associated (Cas) Genes Sales Volume by Application (2018-2023)

    • Table Southwest China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Figure Southwest China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Table Northwest China CRISPR and CRISPR-associated (Cas) Genes Production Volume by Type (2018-2023)

    • Table Northwest China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Figure Northwest China CRISPR and CRISPR-associated (Cas) Genes Production Volume Share by Type (2018-2023)

    • Table Northwest China CRISPR and CRISPR-associated (Cas) Genes Sales Volume by Application (2018-2023)

    • Table Northwest China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Figure Northwest China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share by Application (2018-2023)

    • Table GE Healthcare Dharmacon Company Profile

    • Table GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)

    • Table Mirus Bio LLC Company Profile

    • Table Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)

    • Table Caribou Biosciences Company Profile

    • Table Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Company Profile

    • Table Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)

    • Table Addgene Company Profile

    • Table Addgene CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)

    • Table CRISPR THERAPEUTICS Company Profile

    • Table CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)

    • Table Merck KGaA Company Profile

    • Table Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)

    • Table Editas Medicine Company Profile

    • Table Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)

    • Table Horizon Discovery Group Company Profile

    • Table Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US